3D Systems and United Therapeutics achieved progress in the development of the Print to Perfusion process, which is designed to enable the 3D printing of high-resolution scaffolds that can be perfused with living cells to create tissues.
Combining 3D Systems’ capabilities in additive manufacturing hardware, software, materials, and United Therapeutic’s expertise in regenerative medicine, the two companies have achieved advances in lung modeling and material formulation and handling to improve the capabilities of 3D Systems’ bioprinters and biomaterials for lung manufacturing
US 3D printer OEM 3D Systems has announced intentions to significantly increase the expansion of its regenerative medicine and bioprinting offerings after seeing “tremendous progress” in the development of 3D printing systems for solid-organ scaffolds. Carried out in partnership with United Therapeutics Corporation and its organ manufacturing subsidiary Lung Biotechnology PBC, 3D Systems’ efforts in […]